Loading company…
Otonomy develops drug delivery therapies for ear diseases, including hearing loss and tinnitus.
Founded in 2008 and based in San Diego, US, Otonomy develops therapies for ear conditions such as hearing loss and tinnitus. Its products include a sustained-release drug formulation for chronic ear conditions. The company raised USD 30.10 mn across funding rounds, with its latest deal a private placement in April 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in